TABLE 3.

Clinical trials of macrophage repolarization immunotherapy in gastric cancer.

Target	Class	Compound	Combination/monotherapy	Clinical phase/study type	Sponsors/collaborators	ClinicalTrials.gov ID no.	Status
HER‐2 overexpressing tumours	CAR‐macrophages	CT‐0508	Monotherapy	Phase 1/interventional	National Center for Tumour Diseases, Heidelberg/University Hospital Heidelberg Carisma Therapeutics Inc.	NCT04660929	Recruiting
CSF‐1/CSF‐1R axis	CSF‐1 inhibitors	MCS110	MCS110/PDR001 combination	Phase 2/interventional	Seoul National University Hospital	NCT03694977	Recruiting
Claudin 18.2 and CD47	Claudin 18.2 and CD47 inhibitors	PT886	Monotherapy	Phase 1/interventional	MD Anderson Cancer Center/Phanes Therapeutics	NCT05482893	Recruiting